Arformoterol
A long-acting beta-adrenoceptor agonist used in the treatment of chronic obstructive pulmonary disease
Arformoterol is a long-acting beta-adrenoceptor agonist (LABA) used in the management of chronic obstructive pulmonary disease (COPD). It is the (R,R)-enantiomer of formoterol, which is responsible for the drug's bronchodilatory effects. Arformoterol is marketed under the brand name Brovana and is administered via inhalation.
Pharmacology[edit | edit source]
Arformoterol works by stimulating beta-2 adrenergic receptors in the bronchial smooth muscle, leading to muscle relaxation and bronchodilation. This action helps to alleviate symptoms of COPD such as shortness of breath and wheezing.
Mechanism of Action[edit | edit source]
The drug binds to beta-2 adrenergic receptors, which are G protein-coupled receptors located on the surface of bronchial smooth muscle cells. Upon activation, these receptors initiate a cascade of intracellular events that result in the relaxation of smooth muscle fibers, thereby dilating the airways and improving airflow.
Pharmacokinetics[edit | edit source]
Arformoterol is administered via inhalation, allowing for direct delivery to the lungs. It has a rapid onset of action, typically within 20 minutes, and its effects can last up to 12 hours, making it suitable for twice-daily dosing. The drug is metabolized primarily in the liver and excreted in the urine.
Clinical Use[edit | edit source]
Arformoterol is indicated for the long-term maintenance treatment of bronchoconstriction in patients with COPD, including chronic bronchitis and emphysema. It is not intended for the relief of acute bronchospasm or for the treatment of asthma.
Side Effects[edit | edit source]
Common side effects of arformoterol include tremor, nervousness, and headache. As with other beta-agonists, it may cause cardiovascular effects such as increased heart rate and blood pressure. Patients should be monitored for signs of worsening asthma or paradoxical bronchospasm.
Illustration of Skeletal Muscle[edit | edit source]
Related Pages[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
